Cat#:Y07801N
Name:Recombinant Human TGF-β2
Species:Human
Purity:≥95%
Endotoxin: ≤10 EU/mg
Expression System:CHO
Size: 50μg 1mg
Price: $423.00 $3,540.00
Instruction
Cat#:Y07801N
Name:Recombinant Human TGF-β2
Species:Human
Purity:≥95%
Endotoxin: ≤10 EU/mg
Expression System:CHO
Size: 50μg 1mg
Price: $423.00 $3,540.00
General description
Transforming Growth Factor Beta 2 (TGF-β2) is a secreted cytokine involved in embryonic development, tissue morphogenesis, and immune modulation. It exhibits distinct biological activities from TGF-β1 in neural and ocular systems. Recombinant Human TGF-β2 Protein (Y07801N) is expressed from mammalian cells. It contains AA Ala 303 - Ser 414 (Accession # P61812), and is widely used in advanced cell culture, developmental biology, and ophthalmology research.
Application
· Neural Stem Cell Differentiation — Promotes neuronal and glial lineage specification.
· Ocular Tissue Engineering — Supports corneal endothelial and retinal pigment epithelium culture.
· Chondrogenic Differentiation — Drives cartilage matrix formation in MSC-based tissue engineering.
· Immune Modulation Studies — Investigate context-dependent immunosuppressive mechanisms.
· Serum-Free Culture Systems — Suitable for chemically defined and xeno-free cell culture media.
Product Specifications
Cat. No. | Y07801N |
Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining). |
Endotoxin | ≤10 EU/mg by the LAL method. |
Bioactivity | Measured in a cell inhibition assay using TF-1 cells at IL4 presence. The ED50 for this effect is ≤0.3ng/mL. |
Accession | P61812 |
Alternative Names | Transforming growth factor beta-2; TGFB2; Polyergin; G-TSF; Glioblastoma-derived T-cell suppressor factor; Cetermin; BSC-1 cell growth inhibitor; TGF-beta-2 |
Species | Human |
Expression System | CHO |
Mol. Weight | 12.7 kDa |
Expression Region | Ala 303-Ser 414 |
Tag Info | Tag free |
Formulation | Lyophilized |
Buffer | 0.085% TFA, 30% ACN, 5% Mannitol, pH 2.5. |
Lead Time | Products are in stock, but custom products may require further consultation. |
Shipping | The product is shipped with blue ice. |
Stability and Reconstitution
· 36 months at -20°C to -80°C in lyophilized state;
· 6 months at -20°C to -80°C under sterile conditions after reconstitution;
· 7-10 days at 2°C to 8°C under sterile conditions after reconstitution;
· Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
· It is recommended to redissolve in 4 mM HCL.
Backgroud
Transforming Growth Factor Beta 2 (TGF-β2), also known as G-TSF or cetermin, is a member of the TGF-β superfamily. TGF-β2 shares approximately 70% sequence homology with TGF-β1 but exhibits unique expression patterns and receptor-binding affinities. It is the predominant TGF-β isoform in neural and ocular tissues and plays critical roles in blood-brain barrier maintenance, lens epithelial cell behavior, and palatal fusion during embryogenesis. TGF-β2 signals through the same receptor complex as TGF-β1 but can elicit distinct cellular responses depending on cellular context and co-receptor expression.
Q&A
Q1: What is TGF-β2 mainly used for?
TGF-β2 is primarily used for neural differentiation, ocular tissue culture, chondrogenesis, and developmental biology research.
Q2: Is this TGF-β2 suitable for serum-free culture systems?
Yes. EastMabBio recombinant TGF-β2 is compatible with serum-free, xeno-free, and chemically defined media systems.
Q3: How should recombinant TGF-β2 be stored?
Lyophilized protein should be stored at -20°C or below. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Q4: What shipping conditions are used?
Products are shipped on dry ice with validated cold-chain packaging to maintain stability during international transportation.
Q5: Do you provide QC documents?
Yes. COA, MSDS, TSE-BSE statements, endotoxin reports, bioactivity data, and additional QC documentation are available upon request.
SDS-PAGE

Recombinant Human TGF-β2 (Cat. No. Y07801N) SDS-PAGE under reducing (R) & Non-reducing (NR) condition.
Bioactivity

Measured in a cell inhibition assay using TF-1 cells at IL4 presence. The ED50 for this effect is ≤0.3ng/mL.


SEC-HPLC

Jiangsu East-Mab Bio:Building 13 and 17, 888 Zhujiang Road, Nantong, Jiangsu 226499 , China
Suzhou East-Mab Bio:Floor 5 & 6, Building 1, 168 Majian Road, Suzhou, Jiangsu 215129, China
Platform Information Submission-Privacy Agreement
· Privacy Policy
No content yet
Platform Information Statement-Laws and Regulations
· Laws and regulations
Trademark registration of Jiangsu Dongkang Biomedical Technology Co., Ltd.
East Mab
East Mab Bio
东抗生物
To download COA, please enter the product batch and specification information in the search box.
You can also ask us directly via the following email: dongkang@Sales.com